Fluvastatin

Basic Information

Item Value
DrugBank ID DB01095
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 61

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 hyperlipoproteinemia KG + DL
2 homozygous familial hypercholesterolemia KG + DL
3 hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency KG + DL
4 familial hypercholesterolemia KG + DL
5 HIV infectious disease KG + DL
6 cholesterol-ester transfer protein deficiency KG + DL
7 neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter KG + DL
8 feline acquired immunodeficiency syndrome KG + DL
9 simian immunodeficiency virus infection KG + DL
10 fibroma of prostate KG + DL
11 prostate cancer/brain cancer susceptibility KG + DL
12 hypercholesterolemia, autosomal dominant KG + DL
13 cerebral atherosclerosis KG + DL
14 generalized atherosclerosis KG + DL
15 benign reproductive system neoplasm KG + DL
16 benign prostate phyllodes tumor KG + DL
17 Brenner tumor KG + DL
18 hyperlipidemia due to hepatic triglyceride lipase deficiency KG + DL
19 male reproductive organ cancer KG + DL
20 prostate leiomyoma KG + DL
21 female breast carcinoma KG + DL
22 coronary atherosclerosis KG + DL
23 AIDS KG + DL
24 prostate neoplasm KG + DL
25 familial hyperlipidemia KG + DL
26 hyperalphalipoproteinemia KG + DL
27 benign mammary dysplasia KG + DL
28 familial chylomicronemia syndrome KG + DL
29 breast fibrocystic disease KG + DL
30 hyperlipidemia KG + DL
31 hypertriglyceridemia, familial KG + DL
32 AIDS related complex KG + DL
33 congenital human immunodeficiency virus KG + DL
34 hypolipoproteinemia (disease) KG + DL
35 apocrine adenosis of breast KG + DL
36 blunt duct adenosis of breast KG + DL
37 retinal telangiectasia KG + DL
38 glaucoma KG + DL
39 breast abscess KG + DL
40 fat necrosis of breast KG + DL
41 retinal microaneurysm KG + DL
42 arteriosclerotic retinopathy KG + DL
43 retinal artery occlusion KG + DL
44 sitosterolemia KG + DL
45 vertebral artery occlusion KG + DL
46 hepatoportal sclerosis KG + DL
47 early-onset familial noncirrhotic portal hypertension KG + DL
48 hepatopulmonary syndrome KG + DL
49 primitive portal vein thrombosis KG + DL
50 idiopathic copper-associated cirrhosis KG + DL

(Showing top 50 of 61 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.